Virtual Medicinal Product (VMP) - Doxorubicin (liposomal) 50mg powder and solvent for suspension for infusion vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Doxorubicin (liposomal) 50mg powder and solvent for suspension for infusion vials Start Date 12-02-2010 End Date
Previous Name Previous Name Doxorubicin (liposomal) 50mg powder and solvent for suspension for injection vials Start Date 02-09-2005 End Date 11-02-2010
Abbreviated Name Abbreviated Name Doxorubicin (liposomal) 50mg inf vials Start Date 12-02-2010
Previous Abbreviated Name Doxorubicin (liposomal) 50mg inj vials Previous Start Date 01-05-2009 Previous End Date 11-02-2010

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous
Form
Powder and solvent for suspension for infusion
Ontology Form/Route
suspensioninfusion.intravenous
Non-availability Indicator
Actual Products not Available
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
L01DB01
BNF Start Date End Date
Current BNF 08010200 Start Date 04-04-2022 End Date
Previous BNF 08010200 Start Date 02-09-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
9526811000001106 02-09-2005

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Doxorubicin citrate complex liposomal Based on Base Substance Doxorubicin hydrochloride 50 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
2 vial